Global Arteriovenous Fistula Treatment Market

Arteriovenous Fistula Treatment Comprehensive Study by Type (Drugs, Transcatheter Embolization, Ultrasound-guided Compression, Surgery), Application (Diagnostic Centers, Hospitals, Clinics, Homecare, Ambulatory Surgery Centers), Drug Type (Vascugel, Dipyridamole, PRT-201, Aspirin, Others), Arteriovenous Fistulas Types (Dural Arteriovenous Fistulas, Peripheral Arteriovenous Fistulas, Pial or Cerebral Arteriovenous Fistulas) Players and Region - Global Market Outlook to 2028

Arteriovenous Fistula Treatment Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Arteriovenous Fistula Treatment Market Scope?
The arteriovenous fistula is a disorder of blood flow due to an abnormal connection between a vein and an artery. In an arteriovenous fistula, the blood flows directly from the arteries to the vein, bypassing the capillaries. Thus, capillary tissues receive a lower supply of oxygen (i.e. blood supply) and increase the risk of blood pressure problems. The arteriovenous fistula can be congenital or acquired. Congenital fistula is formed during the development of the fetus and mainly affects the lower extremities of the blood vessels. While acquired fistula usually occurs when veins and arteries are damaged and the healing process results within two parallel connections of the vein and artery. The arteriovenous fistula develops on the arms, kidneys, brain, s, or some parts of the legs. Various diseases such as piercing injuries, arterial vein rupture, and inflammatory necrosis of adjacent vessels increase the risk of an arteriovenous fistula. Deviations in blood pressure, swelling in the legs or arms, heart failure, tiredness, and a reddish appearance on the surface of the skin are common symptoms of an arteriovenous fistula. In addition, blood clots, heart failure, bleeding, and stroke are some of the complications associated with this disorder. The main goal of arteriovenous fistula treatment is to eliminate blood flow between the affected blood vessels. Imaging tests such as computed tomography (CT) and magnetic resonance imaging (MRI) are useful for doctors to determine the exact size and location of the affected blood vessels. The arteriovenous fistula treatment market is a growing market over the forecast period. Some of the new treatment methods that are available are namely photodynamic therapy, antiangiogenic therapy, and some other methods of sclerotherapy. The effective treatment method for a complete cure in an easy way is still in the development process, which prompts players to come up with new innovations for the treatment. Consciousness is an obstacle to the arteriovenous fistula.

Influencing Trend:
Increasing Healthcare Awareness among the Patient Population and Presence of a Large Number of Therapeutics under Clinical Pipeline Coupled With Positive Initiatives by Government

Market Growth Drivers:
Growing Geriatric Population, Increasing the Prevalence of End-Stage Renal Disease, Rising Per Capita Healthcare Expenditure and Increasing Population, Insurance Coverage, Better Healthcare Facilities

Challenges:
The Lack of Awareness about Arteriovenous Fistula Treatment

Restraints:
Lack of Effective Therapeutics That Enables To Target Specific Cause of Arteriovenous Fistula

Opportunities:
Technological Innovation in Arteriovenous Fistula Treatment and Favorable Insurance and Reimbursement Policies

The Arteriovenous Fistula Treatment market study is being classified by Type (Drugs, Transcatheter Embolization, Ultrasound-guided Compression and Surgery), by Application and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Arteriovenous Fistula Treatment market throughout the predicted period.

Becton Dickinson (United States), Medtronic (Ireland), Cook Medical (United States), Teleflex Incorporated (United States), Fresenius Medical Care AG & Co. KGaA (Germany), NxStage Medical (United States), Poly Medicure Limited (India) and B. Braun (Germany) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Arteriovenous Fistula Treatment market by Type, Application and Region.

On the basis of geography, the market of Arteriovenous Fistula Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies
In September 2020, Medtronic acquired Avenu Medical, developers of a minimally invasive method of building the blood vessel access ports used by patients receiving dialysis treatments. This acquisition helped company to expand its presence in arteriovenous fistula treatment market
In April, 2021, BD started treatment for first patients in the post-market surveillance study, CONNECT-AV. CONNECT-AV is a prospective, single-arm, open-label study that followed patients treated with the WavelinQTM EndoAVF System for 24 months. This helped company to expand its presence in arteriovenous fistula treatment market


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Arteriovenous Fistula Treatment, Venture Capitalists and Private Equity Firms and End-Use Industry

Arteriovenous Fistula Treatment Market Study: Important Years
AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Arteriovenous Fistula Treatment Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Arteriovenous Fistula Treatment industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Drugs
  • Transcatheter Embolization
  • Ultrasound-guided Compression
  • Surgery
By Application
  • Diagnostic Centers
  • Hospitals
  • Clinics
  • Homecare
  • Ambulatory Surgery Centers
By Drug Type
  • Vascugel
  • Dipyridamole
  • PRT-201
  • Aspirin
  • Others

By Arteriovenous Fistulas Types
  • Dural Arteriovenous Fistulas
  • Peripheral Arteriovenous Fistulas
  • Pial or Cerebral Arteriovenous Fistulas

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Geriatric Population
      • 3.2.2. Increasing the Prevalence of End-Stage Renal Disease
      • 3.2.3. Rising Per Capita Healthcare Expenditure
      • 3.2.4. Increasing Population, Insurance Coverage, Better Healthcare Facilities
    • 3.3. Market Challenges
      • 3.3.1. The Lack of Awareness about Arteriovenous Fistula Treatment
    • 3.4. Market Trends
      • 3.4.1. Increasing Healthcare Awareness among the Patient Population
      • 3.4.2. Presence of a Large Number of Therapeutics under Clinical Pipeline Coupled With Positive Initiatives by Government
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Arteriovenous Fistula Treatment, by Type, Application, Drug Type, Arteriovenous Fistulas Types and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Arteriovenous Fistula Treatment (Value)
      • 5.2.1. Global Arteriovenous Fistula Treatment by: Type (Value)
        • 5.2.1.1. Drugs
        • 5.2.1.2. Transcatheter Embolization
        • 5.2.1.3. Ultrasound-guided Compression
        • 5.2.1.4. Surgery
      • 5.2.2. Global Arteriovenous Fistula Treatment by: Application (Value)
        • 5.2.2.1. Diagnostic Centers
        • 5.2.2.2. Hospitals
        • 5.2.2.3. Clinics
        • 5.2.2.4. Homecare
        • 5.2.2.5. Ambulatory Surgery Centers
      • 5.2.3. Global Arteriovenous Fistula Treatment by: Drug Type (Value)
        • 5.2.3.1. Vascugel
        • 5.2.3.2. Dipyridamole
        • 5.2.3.3. PRT-201
        • 5.2.3.4. Aspirin
        • 5.2.3.5. Others
      • 5.2.4. Global Arteriovenous Fistula Treatment by: Arteriovenous Fistulas Types (Value)
        • 5.2.4.1. Dural Arteriovenous Fistulas
        • 5.2.4.2. Peripheral Arteriovenous Fistulas
        • 5.2.4.3. Pial or Cerebral Arteriovenous Fistulas
      • 5.2.5. Global Arteriovenous Fistula Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Arteriovenous Fistula Treatment (Price)
      • 5.3.1. Global Arteriovenous Fistula Treatment by: Type (Price)
  • 6. Arteriovenous Fistula Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton Dickinson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cook Medical (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Teleflex Incorporated (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Fresenius Medical Care AG & Co. KGaA (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. NxStage Medical (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Poly Medicure Limited (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. B. Braun (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Arteriovenous Fistula Treatment Sale, by Type, Application, Drug Type, Arteriovenous Fistulas Types and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Arteriovenous Fistula Treatment (Value)
      • 7.2.1. Global Arteriovenous Fistula Treatment by: Type (Value)
        • 7.2.1.1. Drugs
        • 7.2.1.2. Transcatheter Embolization
        • 7.2.1.3. Ultrasound-guided Compression
        • 7.2.1.4. Surgery
      • 7.2.2. Global Arteriovenous Fistula Treatment by: Application (Value)
        • 7.2.2.1. Diagnostic Centers
        • 7.2.2.2. Hospitals
        • 7.2.2.3. Clinics
        • 7.2.2.4. Homecare
        • 7.2.2.5. Ambulatory Surgery Centers
      • 7.2.3. Global Arteriovenous Fistula Treatment by: Drug Type (Value)
        • 7.2.3.1. Vascugel
        • 7.2.3.2. Dipyridamole
        • 7.2.3.3. PRT-201
        • 7.2.3.4. Aspirin
        • 7.2.3.5. Others
      • 7.2.4. Global Arteriovenous Fistula Treatment by: Arteriovenous Fistulas Types (Value)
        • 7.2.4.1. Dural Arteriovenous Fistulas
        • 7.2.4.2. Peripheral Arteriovenous Fistulas
        • 7.2.4.3. Pial or Cerebral Arteriovenous Fistulas
      • 7.2.5. Global Arteriovenous Fistula Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Arteriovenous Fistula Treatment (Price)
      • 7.3.1. Global Arteriovenous Fistula Treatment by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Arteriovenous Fistula Treatment: by Type(USD Million)
  • Table 2. Arteriovenous Fistula Treatment Drugs , by Region USD Million (2017-2022)
  • Table 3. Arteriovenous Fistula Treatment Transcatheter Embolization , by Region USD Million (2017-2022)
  • Table 4. Arteriovenous Fistula Treatment Ultrasound-guided Compression , by Region USD Million (2017-2022)
  • Table 5. Arteriovenous Fistula Treatment Surgery , by Region USD Million (2017-2022)
  • Table 6. Arteriovenous Fistula Treatment: by Application(USD Million)
  • Table 7. Arteriovenous Fistula Treatment Diagnostic Centers , by Region USD Million (2017-2022)
  • Table 8. Arteriovenous Fistula Treatment Hospitals , by Region USD Million (2017-2022)
  • Table 9. Arteriovenous Fistula Treatment Clinics , by Region USD Million (2017-2022)
  • Table 10. Arteriovenous Fistula Treatment Homecare , by Region USD Million (2017-2022)
  • Table 11. Arteriovenous Fistula Treatment Ambulatory Surgery Centers , by Region USD Million (2017-2022)
  • Table 12. Arteriovenous Fistula Treatment: by Drug Type(USD Million)
  • Table 13. Arteriovenous Fistula Treatment Vascugel , by Region USD Million (2017-2022)
  • Table 14. Arteriovenous Fistula Treatment Dipyridamole , by Region USD Million (2017-2022)
  • Table 15. Arteriovenous Fistula Treatment PRT-201 , by Region USD Million (2017-2022)
  • Table 16. Arteriovenous Fistula Treatment Aspirin , by Region USD Million (2017-2022)
  • Table 17. Arteriovenous Fistula Treatment Others , by Region USD Million (2017-2022)
  • Table 18. Arteriovenous Fistula Treatment: by Arteriovenous Fistulas Types(USD Million)
  • Table 19. Arteriovenous Fistula Treatment Dural Arteriovenous Fistulas , by Region USD Million (2017-2022)
  • Table 20. Arteriovenous Fistula Treatment Peripheral Arteriovenous Fistulas , by Region USD Million (2017-2022)
  • Table 21. Arteriovenous Fistula Treatment Pial or Cerebral Arteriovenous Fistulas , by Region USD Million (2017-2022)
  • Table 22. South America Arteriovenous Fistula Treatment, by Country USD Million (2017-2022)
  • Table 23. South America Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 24. South America Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 25. South America Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 26. South America Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 27. Brazil Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 28. Brazil Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 29. Brazil Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 30. Brazil Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 31. Argentina Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 32. Argentina Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 33. Argentina Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 34. Argentina Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 35. Rest of South America Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 36. Rest of South America Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 37. Rest of South America Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 38. Rest of South America Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 39. Asia Pacific Arteriovenous Fistula Treatment, by Country USD Million (2017-2022)
  • Table 40. Asia Pacific Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 41. Asia Pacific Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 42. Asia Pacific Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 43. Asia Pacific Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 44. China Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 45. China Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 46. China Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 47. China Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 48. Japan Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 49. Japan Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 50. Japan Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 51. Japan Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 52. India Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 53. India Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 54. India Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 55. India Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 56. South Korea Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 57. South Korea Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 58. South Korea Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 59. South Korea Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 60. Taiwan Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 61. Taiwan Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 62. Taiwan Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 63. Taiwan Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 64. Australia Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 65. Australia Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 66. Australia Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 67. Australia Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 71. Rest of Asia-Pacific Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 72. Europe Arteriovenous Fistula Treatment, by Country USD Million (2017-2022)
  • Table 73. Europe Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 74. Europe Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 75. Europe Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 76. Europe Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 77. Germany Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 78. Germany Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 79. Germany Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 80. Germany Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 81. France Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 82. France Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 83. France Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 84. France Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 85. Italy Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 86. Italy Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 87. Italy Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 88. Italy Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 89. United Kingdom Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 90. United Kingdom Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 91. United Kingdom Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 92. United Kingdom Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 93. Netherlands Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 94. Netherlands Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 95. Netherlands Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 96. Netherlands Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 97. Rest of Europe Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 98. Rest of Europe Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 99. Rest of Europe Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 100. Rest of Europe Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 101. MEA Arteriovenous Fistula Treatment, by Country USD Million (2017-2022)
  • Table 102. MEA Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 103. MEA Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 104. MEA Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 105. MEA Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 106. Middle East Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 107. Middle East Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 108. Middle East Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 109. Middle East Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 110. Africa Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 111. Africa Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 112. Africa Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 113. Africa Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 114. North America Arteriovenous Fistula Treatment, by Country USD Million (2017-2022)
  • Table 115. North America Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 116. North America Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 117. North America Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 118. North America Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 119. United States Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 120. United States Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 121. United States Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 122. United States Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 123. Canada Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 124. Canada Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 125. Canada Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 126. Canada Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 127. Mexico Arteriovenous Fistula Treatment, by Type USD Million (2017-2022)
  • Table 128. Mexico Arteriovenous Fistula Treatment, by Application USD Million (2017-2022)
  • Table 129. Mexico Arteriovenous Fistula Treatment, by Drug Type USD Million (2017-2022)
  • Table 130. Mexico Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Table 131. Arteriovenous Fistula Treatment: by Type(USD/Units)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Arteriovenous Fistula Treatment: by Type(USD Million)
  • Table 141. Arteriovenous Fistula Treatment Drugs , by Region USD Million (2023-2028)
  • Table 142. Arteriovenous Fistula Treatment Transcatheter Embolization , by Region USD Million (2023-2028)
  • Table 143. Arteriovenous Fistula Treatment Ultrasound-guided Compression , by Region USD Million (2023-2028)
  • Table 144. Arteriovenous Fistula Treatment Surgery , by Region USD Million (2023-2028)
  • Table 145. Arteriovenous Fistula Treatment: by Application(USD Million)
  • Table 146. Arteriovenous Fistula Treatment Diagnostic Centers , by Region USD Million (2023-2028)
  • Table 147. Arteriovenous Fistula Treatment Hospitals , by Region USD Million (2023-2028)
  • Table 148. Arteriovenous Fistula Treatment Clinics , by Region USD Million (2023-2028)
  • Table 149. Arteriovenous Fistula Treatment Homecare , by Region USD Million (2023-2028)
  • Table 150. Arteriovenous Fistula Treatment Ambulatory Surgery Centers , by Region USD Million (2023-2028)
  • Table 151. Arteriovenous Fistula Treatment: by Drug Type(USD Million)
  • Table 152. Arteriovenous Fistula Treatment Vascugel , by Region USD Million (2023-2028)
  • Table 153. Arteriovenous Fistula Treatment Dipyridamole , by Region USD Million (2023-2028)
  • Table 154. Arteriovenous Fistula Treatment PRT-201 , by Region USD Million (2023-2028)
  • Table 155. Arteriovenous Fistula Treatment Aspirin , by Region USD Million (2023-2028)
  • Table 156. Arteriovenous Fistula Treatment Others , by Region USD Million (2023-2028)
  • Table 157. Arteriovenous Fistula Treatment: by Arteriovenous Fistulas Types(USD Million)
  • Table 158. Arteriovenous Fistula Treatment Dural Arteriovenous Fistulas , by Region USD Million (2023-2028)
  • Table 159. Arteriovenous Fistula Treatment Peripheral Arteriovenous Fistulas , by Region USD Million (2023-2028)
  • Table 160. Arteriovenous Fistula Treatment Pial or Cerebral Arteriovenous Fistulas , by Region USD Million (2023-2028)
  • Table 161. South America Arteriovenous Fistula Treatment, by Country USD Million (2023-2028)
  • Table 162. South America Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 163. South America Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 164. South America Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 165. South America Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 166. Brazil Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 167. Brazil Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 168. Brazil Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 169. Brazil Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 170. Argentina Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 171. Argentina Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 172. Argentina Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 173. Argentina Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 174. Rest of South America Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 175. Rest of South America Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 176. Rest of South America Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 177. Rest of South America Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 178. Asia Pacific Arteriovenous Fistula Treatment, by Country USD Million (2023-2028)
  • Table 179. Asia Pacific Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 180. Asia Pacific Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 181. Asia Pacific Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 182. Asia Pacific Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 183. China Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 184. China Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 185. China Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 186. China Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 187. Japan Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 188. Japan Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 189. Japan Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 190. Japan Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 191. India Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 192. India Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 193. India Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 194. India Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 195. South Korea Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 196. South Korea Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 197. South Korea Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 198. South Korea Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 199. Taiwan Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 200. Taiwan Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 201. Taiwan Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 202. Taiwan Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 203. Australia Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 204. Australia Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 205. Australia Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 206. Australia Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 207. Rest of Asia-Pacific Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 208. Rest of Asia-Pacific Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 209. Rest of Asia-Pacific Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 210. Rest of Asia-Pacific Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 211. Europe Arteriovenous Fistula Treatment, by Country USD Million (2023-2028)
  • Table 212. Europe Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 213. Europe Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 214. Europe Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 215. Europe Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 216. Germany Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 217. Germany Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 218. Germany Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 219. Germany Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 220. France Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 221. France Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 222. France Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 223. France Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 224. Italy Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 225. Italy Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 226. Italy Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 227. Italy Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 228. United Kingdom Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 229. United Kingdom Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 230. United Kingdom Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 231. United Kingdom Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 232. Netherlands Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 233. Netherlands Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 234. Netherlands Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 235. Netherlands Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 236. Rest of Europe Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 237. Rest of Europe Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 238. Rest of Europe Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 239. Rest of Europe Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 240. MEA Arteriovenous Fistula Treatment, by Country USD Million (2023-2028)
  • Table 241. MEA Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 242. MEA Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 243. MEA Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 244. MEA Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 245. Middle East Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 246. Middle East Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 247. Middle East Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 248. Middle East Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 249. Africa Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 250. Africa Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 251. Africa Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 252. Africa Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 253. North America Arteriovenous Fistula Treatment, by Country USD Million (2023-2028)
  • Table 254. North America Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 255. North America Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 256. North America Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 257. North America Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 258. United States Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 259. United States Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 260. United States Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 261. United States Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 262. Canada Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 263. Canada Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 264. Canada Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 265. Canada Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 266. Mexico Arteriovenous Fistula Treatment, by Type USD Million (2023-2028)
  • Table 267. Mexico Arteriovenous Fistula Treatment, by Application USD Million (2023-2028)
  • Table 268. Mexico Arteriovenous Fistula Treatment, by Drug Type USD Million (2023-2028)
  • Table 269. Mexico Arteriovenous Fistula Treatment, by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Table 270. Arteriovenous Fistula Treatment: by Type(USD/Units)
  • Table 271. Research Programs/Design for This Report
  • Table 272. Key Data Information from Secondary Sources
  • Table 273. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Arteriovenous Fistula Treatment: by Type USD Million (2017-2022)
  • Figure 5. Global Arteriovenous Fistula Treatment: by Application USD Million (2017-2022)
  • Figure 6. Global Arteriovenous Fistula Treatment: by Drug Type USD Million (2017-2022)
  • Figure 7. Global Arteriovenous Fistula Treatment: by Arteriovenous Fistulas Types USD Million (2017-2022)
  • Figure 8. South America Arteriovenous Fistula Treatment Share (%), by Country
  • Figure 9. Asia Pacific Arteriovenous Fistula Treatment Share (%), by Country
  • Figure 10. Europe Arteriovenous Fistula Treatment Share (%), by Country
  • Figure 11. MEA Arteriovenous Fistula Treatment Share (%), by Country
  • Figure 12. North America Arteriovenous Fistula Treatment Share (%), by Country
  • Figure 13. Global Arteriovenous Fistula Treatment: by Type USD/Units (2017-2022)
  • Figure 14. Global Arteriovenous Fistula Treatment share by Players 2022 (%)
  • Figure 15. Global Arteriovenous Fistula Treatment share by Players (Top 3) 2022(%)
  • Figure 16. Global Arteriovenous Fistula Treatment share by Players (Top 5) 2022(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 19. Becton Dickinson (United States) Revenue: by Geography 2022
  • Figure 20. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 21. Medtronic (Ireland) Revenue: by Geography 2022
  • Figure 22. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 23. Cook Medical (United States) Revenue: by Geography 2022
  • Figure 24. Teleflex Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 25. Teleflex Incorporated (United States) Revenue: by Geography 2022
  • Figure 26. Fresenius Medical Care AG & Co. KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Fresenius Medical Care AG & Co. KGaA (Germany) Revenue: by Geography 2022
  • Figure 28. NxStage Medical (United States) Revenue, Net Income and Gross profit
  • Figure 29. NxStage Medical (United States) Revenue: by Geography 2022
  • Figure 30. Poly Medicure Limited (India) Revenue, Net Income and Gross profit
  • Figure 31. Poly Medicure Limited (India) Revenue: by Geography 2022
  • Figure 32. B. Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 33. B. Braun (Germany) Revenue: by Geography 2022
  • Figure 34. Global Arteriovenous Fistula Treatment: by Type USD Million (2023-2028)
  • Figure 35. Global Arteriovenous Fistula Treatment: by Application USD Million (2023-2028)
  • Figure 36. Global Arteriovenous Fistula Treatment: by Drug Type USD Million (2023-2028)
  • Figure 37. Global Arteriovenous Fistula Treatment: by Arteriovenous Fistulas Types USD Million (2023-2028)
  • Figure 38. South America Arteriovenous Fistula Treatment Share (%), by Country
  • Figure 39. Asia Pacific Arteriovenous Fistula Treatment Share (%), by Country
  • Figure 40. Europe Arteriovenous Fistula Treatment Share (%), by Country
  • Figure 41. MEA Arteriovenous Fistula Treatment Share (%), by Country
  • Figure 42. North America Arteriovenous Fistula Treatment Share (%), by Country
  • Figure 43. Global Arteriovenous Fistula Treatment: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Becton Dickinson (United States)
  • Medtronic (Ireland)
  • Cook Medical (United States)
  • Teleflex Incorporated (United States)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • NxStage Medical (United States)
  • Poly Medicure Limited (India)
  • B. Braun (Germany)
Select User Access Type

Key Highlights of Report


Jul 2023 240 Pages 77 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Arteriovenous Fistula Treatment Market Quantitative research analysis
Global Arteriovenous Fistula Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Arteriovenous Fistula Treatment market are Becton Dickinson (United States), Medtronic (Ireland), Cook Medical (United States), Teleflex Incorporated (United States), Fresenius Medical Care AG & Co. KGaA (Germany), NxStage Medical (United States), Poly Medicure Limited (India) and B. Braun (Germany).
In this highly competitive & fast evolving Arteriovenous Fistula Treatment industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
Diagnostic Centers, Hospitals, Clinics, Homecare and Ambulatory Surgery Centers are the potential customers of Arteriovenous Fistula Treatment industry.

Know More About Global Arteriovenous Fistula Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Brucellosis Vaccines Comprehensive Study by Type (DNA Vaccines, Subunit Vaccines, Vector Vaccines, B. Abortus Recombinant Mutants, Others), Application (Cattle, Sheep, Goats, Pigs, Others), Distribut...
$ 3750
Drugs for Vulvovaginal Candidiasis Comprehensive Study by Type (Miconazole, Clotrimazole, Fluconazole, Econazole, Other), Application (Clotrimazole,, Miconazole,, Terconazole,, Tioconazole,), Formula...
$ 3500
Achondroplasia Treatment Comprehensive Study by Type (RBM-007, TA-46, B-701, Others), Application (Hospital, Clinic, Others) Players and Region - Global Market Outlook to 2030
$ 3500
Hemoperfusion Comprehensive Study by Type (Charcoal Hemoperfusion, Certain Resins Hemoperfusion), Application (Drug Intoxication, Hepatic Encephalopathy, Others), Hemoperfusion Devices (DiaKart, Bioc...
$ 3750
Etanercept Comprehensive Study by Type (Enbrel, Benepali), Application (Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis, Juvenile idiopathic arthritis (JIA), Others), Form Type (Inj...
$ 3650
Radiotherapy Comprehensive Study by Type (External Beam Radiotherapy (IMRT, IGRT, Others), Internal Beam Radiotherapy (LDR, HDR, PDR), Systemic Radiotherapy), Application (Prostate Cancer, Breast Can...
$ 3750